You are herePharma- und Produktvigilanz, Sicherheit medizinischer Technologien
Pharma- und Produktvigilanz, Sicherheit medizinischer Technologien
Tags
ASHP - American Society of Health-System Pharmacists - Health-System Pharmacy News
BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
- Rote-Hand-Brief zu Aclasta® (Wirkstoff: Zoledronsäure): Berichte über Nierenfunktionsstörungen und Nierenversagen
- Ciprofloxacin-haltige Generika: Übertragung der Ergebnisse des Harmonisierungsverfahrens für den Originator auf die Generika
- Info-Brief zu Protopic® (Wirkstoff: Tacrolimus): Empfehlungen zur Kontrolle der Erhaltungstherapie
- Info-Brief zu Protopic® (Wirkstoff: Tacrolismus): Empfehlungen zur Kontrolle der Erhaltungstherapie
- Ergebnisprotokoll der 65. Routinesitzung vom 12.11.2009
Eurosurveillance
- How to define an area where transmission of arthropod-borne disease is occurring?
- Re-emergence of dengue in Réunion, France, January to April 2012
- Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011
- WHO seeking input from health experts into ICD-11
- WHO launches the World Health Statistics 2012
FDA What's New: Drugs
- New and Generic Drug Approvals
- Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)
- Updated Questions and Answers for Healthcare Professionals and the Public: Use an Approved Pancreatic Enzyme Product (PEP)
- Newly Added Guidance Documents
- Current Drug Shortages
FDA What's New: Vaccines, Blood & Biologics
MedEffect Canada - Recent Advisories Warnings and Recalls
- Health Canada Reminds Canadians to Check Medical Device Clocks after Switch to Daylight Savings Time [2010-03-12]
- Fentanyl Transdermal Systems - New Changes to the Dose Conversion Guidelines - Janssen-Ortho Inc., Cobalt Pharmaceuticals Inc., Teva Canada Limited, Ranbaxy Pharmaceuticals Canada Inc., ratiopharm inc., Sandoz Canada Inc. and Pharmascience Inc. For Health
- Unapproved Health Product, "POWER-MAX" May Pose Serious Health Risks [2010-03-08]
- Foreign Product Alert - Tian Yang Xu Huo Oral Ulcer Capsule [2010-03-01]
- Foreign Product Alert - STRO Emperor Capsules [2010-03-01]
Medicines and Healthcare products Regulatory Agency (MHRA) - Drug Safety Update
Medicines and Healthcare products Regulatory Agency (MHRA) - Herbal Medicines Safety Update
- Department of Health in Hong Kong finds Traditional Chinese Medicines to contain heavy metals and undeclared pharmaceuticals
- Paiyouji Plus - Fast Acting Slimming Tea found to contain potentially dangerous undeclared pharmaceuticals
- Herbal slimming products found to contain potentially dangerous undeclared pharmaceuticals
- Advice to consumers not to use unlicensed herbal medicines used for erectile dysfunction
- Consumers are advised not to take unlicensed Butterbur (Petasites hybridus) herbal remedies
Medsafe New Zealand - Prescriber Update Articles
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
- Zithromax (azithromycin): FDA Statement on risk of cardiovascular death
- Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose
- Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume
- Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies
- Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians
Deutsch
English